Inter-joint coordination with and without dopaminergic medication in Parkinson's disease: a case-control study.
Karolina Saegner, Robbin Romijnders, Clint Hansen and 3 others
PMID 39003450WHAT IT FOUND
People with Parkinson's disease showed reduced knee movement and delayed hip flexion during walking, particularly at preferred speeds.
Dopaminergic medication improved hip kinematics only at preferred speed and did not resolve these coordination deficits. Walking faster than usual may improve gait regularity.
Key findings
01Knee range of motion was consistently smaller in people with Parkinson's disease compared to healthy controls across all walking speeds.
02Dopaminergic medication improved hip kinematics significantly only during preferred walking speed, with no significant change in knee range of motion.
03Gait regularity (consistency of hip-knee coordination) was lower in people with Parkinson's disease specifically at preferred walking speed compared to controls.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The medication-off group was very small (only 8 participants), limiting the certainty of on/off comparisons. Participants had to be able to walk independently without aids, so results may not apply to those with more severe mobility limitations. The study focused on straight-line walking over a short distance (5m), which may not reflect complex daily environments. Gait speed was self-selected or instructed but not standardized across trials in a way that controls for all individual variability.
Declared interests
The study was funded by Universitätsklinikum Schleswig-Holstein - Campus Kiel. No specific commercial conflicts of interest were declared in the text.
The easy way to misread this
Do not assume that dopaminergic medication will resolve gait coordination deficits during fast walking or that it improves knee kinematics. The study found medication effects were limited to hip kinematics at preferred speed, and knee deficits persisted regardless of medication status.